These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12884025)

  • 1. p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo.
    Kralj M; Pavelić J
    J Cancer Res Clin Oncol; 2003 Aug; 129(8):463-71. PubMed ID: 12884025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP; Wolf JK; Price JE
    Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells.
    Wu Q; Kirschmeier P; Hockenberry T; Yang TY; Brassard DL; Wang L; McClanahan T; Black S; Rizzi G; Musco ML; Mirza A; Liu S
    J Biol Chem; 2002 Sep; 277(39):36329-37. PubMed ID: 12138103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21 WAF1/CIP1 and p16CDKN4) in human prostate cancers.
    Gotoh A; Kao C; Ko SC; Hamada K; Liu TJ; Chung LW
    J Urol; 1997 Aug; 158(2):636-41. PubMed ID: 9224383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
    Saied IT; Shamsuddin AM
    Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
    Eastham JA; Hall SJ; Sehgal I; Wang J; Timme TL; Yang G; Connell-Crowley L; Elledge SJ; Zhang WW; Harper JW
    Cancer Res; 1995 Nov; 55(22):5151-5. PubMed ID: 7585563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.
    Akimoto T; Seong J; Hunter NR; Buchmiller L; Mason K; Milas L
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):413-9. PubMed ID: 10760438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
    Li JH; Li P; Klamut H; Liu FF
    Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
    Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
    Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells.
    Gorospe M; Cirielli C; Wang X; Seth P; Capogrossi MC; Holbrook NJ
    Oncogene; 1997 Feb; 14(8):929-35. PubMed ID: 9050992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
    Weinrib L; Li JH; Donovan J; Huang D; Liu FF
    Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
    Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
    Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
    Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
    Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis.
    Kondo S; Barna BP; Kondo Y; Tanaka Y; Casey G; Liu J; Morimura T; Kaakaji R; Peterson JW; Werbel B; Barnett GH
    Oncogene; 1996 Sep; 13(6):1279-85. PubMed ID: 8808702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
    Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
    Weinberg WC; Montano NE; Deng C
    Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.